Willow Biosciences (TSE:WLLW) Shares Down 16.7% – Time to Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report) shares were down 16.7% on Wednesday . The company traded as low as C$0.03 and last traded at C$0.03. Approximately 120,500 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 616,818 shares. The stock had previously closed at C$0.03.

Willow Biosciences Price Performance

The business has a 50-day simple moving average of C$0.06 and a two-hundred day simple moving average of C$0.08. The stock has a market capitalization of C$4.33 million, a price-to-earnings ratio of -0.50 and a beta of 1.13. The company has a quick ratio of 19.71, a current ratio of 0.70 and a debt-to-equity ratio of 131.61.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

See Also

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.